Companies / Tvardi Therapeutics, Inc. / Activity
Activity — Tvardi Therapeutics, Inc.
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Shiff Susan Ph.D. Director | Grant | Stock Option (right to buy) | — | +6K | 6,000 0.06% of shares | low |
| Jun 9, 2026 | Hall Wallace L Jr Director | Grant | Stock Option (right to buy) | — | +6K | 6,000 0.06% of shares | low |
| Jun 9, 2026 | Smith Cynthia Director | Grant | Stock Option (right to buy) | — | +6K | 6,000 0.06% of shares | low |
| Jun 9, 2026 | Shah Sujal Director | Grant | Stock Option (right to buy) | — | +6K | 6,000 0.06% of shares | low |
| Jun 9, 2026 | Wyzga Michael S Director | Grant | Stock Option (right to buy) | — | +6K | 6,000 0.06% of shares | low |
| Jan 29, 2026 | Conn Avi Daniel Executive | Grant | Employee Stock Option (right to buy) | — | +45K | 45,000 0.48% of shares | low |
| Jan 29, 2026 | O'Brien Stephen Paul Executive | Grant | Employee Stock Option (right to buy) | — | +15K | 15,000 0.16% of shares | low |
| Jan 29, 2026 | Alibhai Imran Nizamudin CEO | Grant | Employee Stock Option (right to buy) | — | +115K | 115,000 1.23% of shares | low |
| Jan 29, 2026 | Kauh John Saewook M.D. Executive | Grant | Employee Stock Option (right to buy) | — | +45K | 45,000 0.48% of shares | low |